Recurrent and atypical meningiomas - A multi-parametric study using Ki67 labelling index, AgNOR and DNA Feulgen staining

Clinical Neuropathology

Volumn 22, Issue 4, 2003, Pages 187-192

  Ferraraccio, F ^a   Accardo, M ^a   Giangaspero, F ^b   Cuccurullo, L ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b BUFALINI HOSPITAL   (Italy)

Author keywords

Ki67; Meningiomas; Mitoses; Ploidy; Recurrences

Indexed keywords

DNA; KI 67 ANTIGEN;

ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CELL KINETICS; CELL PROLIFERATION; DNA DETERMINATION; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MENINGIOMA; MITOSIS INDEX; PLOIDY; PRIORITY JOURNAL; QUANTITATIVE ASSAY; WORLD HEALTH ORGANIZATION;

CELL DIVISION; COLORING AGENTS; DNA, NEOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MENINGEAL NEOPLASMS; MENINGIOMA; MITOTIC INDEX; NEOPLASM RECURRENCE, LOCAL; NUCLEOLUS ORGANIZER REGION; POLYPLOIDY; PREDICTIVE VALUE OF TESTS; ROSANILINE DYES; SILVER;

EID: 0038155359     PISSN: 07225091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Aaltomaa S, Lipponen P, Syrjänen K 1993 Nucleolar organizer regions related to morphometry, flow cytometry, sex steroid receptor content, tumour histology and prognosis in female breast cancer. Pathol Res Pract 189: 416-421
2. Crafa P, Campanini N, Martella EM, Trabattoni G, Tedeschi F 1994 AgNORs, antigeni nucleo-nucleolo associati (Ki67, PCNA, P105 e p 120) marker di prognosi nella recidiva di meningioma. Acta Bio Med "L'Ateneo Parmense" 65: 297-308
3. de la Monte SM, Flickinger J, Linggood M 1986 Histopathologic features predicting recurrence of meningiomas following subtotal resection. Am J Surg Pathol 10: 836-843
4. Fukui M, Iwaki T, Sawa H, Inone T, Takeshita L, Kitamura K 1986 Proliferative activity of meningiomas as evaluated by bromodeoxyuridine uptake examination. Acta Neurochir 81: 135-141
5. Jääskeläinen J 1986 Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. Surg Neurol 26: 461-469
6. Jellinger K, Slowik F 1975 Histological subtypes and prognostic problems in meningiomas. J Neurol 208: 279-298
7. Kleihues P, Cavenee Webster K 2000 Pathology and Genetics of the Nervous System. IARC Press, Lyon p 314
8. Kolles H, Niedermayer I, Schmitt Ch, Henn W, Feld R, Stendel WI, Zang KD, Feiden W 1995 Triple approach for diagnosis and grading of meningiomas: histology, morphometry of Ki67/Feulgen stainings, and cytogenetics. Acta Neurochir 137: 174-181
9. Korkolopoulou P, Christodoulou P, Papanikolaou A, Thomas-Tsagli E 1993 Proliferating cell nuclear antigen and nucleolar organizer regions in CNS tumors: correlation with histological type and tumor grade. Am J Surg Pathol 17: 912-919
10. Lamszus K, Kluwe L, Matschke J, Laas R, Westphal M 1999 Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas. Cancer Genet Cytogenet 110: 103-10
11. Langford LA, Cooksley CS, De Monte F 1996 Comparison of MIB-1 (Ki67) antigen and bromodeoxyuridine proliferation indices in meningiomas. Hum Pathol 27: 350-354
12. Lee KS, Hoshino T, Rodriguez LA, Bederson J, Davis RL, Wilson CB 1990 Bromodeoxyuridine labeling study of intracranial meningiomas: proliferative potential and recurrence. Acta Neuropathol 80: 311-317
13. Louis DN, Scheithauer BW, Budka H, Von Deimling A, Kepes JJ 2000 Meningiomas. In: Kleinhues P, Webster K-C (eds.): Pathology and Genetics of Tumors of the Nervous System. IARC Press, Lyon, pp 176-184
14. Maillo A, Diaz P, Blanco A, Lopez A, Ciudad J, Hernandez J, Morales F, Perez-Simon JA, Orfao A 1999 Proportion of S-phase tumor cells measured by flow cytometry is an independent prognostic factor in meningioma tumors. Cytometry 38: 118-123
15. Nakaguchi H, Fujimaki T, Matsuno A, Matsuura R, Asai A, Suzuki I, Sasaki T, Kirino T 1999 Postoperative residual tumor growth of meningioma can be predicted by MIB-1 immunohistochemistry. Cancer 85: 2249-2254
16. Perry A, Stafford SL, Scheithauer B W 1997 An analysis of histologic parameters. Am J Surg Pathol 21: 1455-1465
17. Perry A, Stafford Scott L, Scheithauer BW, Suman V, Lohse CM 1998 The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas. Cancer 82: 2262-2269
18. Roggendorf W, Schuster T, Peiffer J 1987 Proliferative potential of meningiomas determined with the monoclonal antibody Ki67. Acta Neuropathol 73: 361-364
19. Salmon I, Kiss R, Leviver M et al 1993 Characterization of nuclear DNA content, proliferation index, and nuclear size in a series of 181 meningiomas, including benign primary, recurrent and malignant tumors. Am J Surg Pathol 17: 239-247
20. Shibuya M, Satoyuki I, Miwa T, Davis RL, Wilson CB, Hoshino T 1993 Proliferative potential of brain tumors. Analyses with Ki67 and anti-DNA polymerase-alpha monoclonal antibodies, bromodeoxyuridine labeling, and nucleolar organizer region counts. Cancer 71: 199-206
21. Skullerud K, Loken AC 1974 The prognosis in meningiomas. Acta Neuropathol 29: 337-344
22. Tonn JC, Ott MN, Bouterfa H, Kerkau S, Kapp M, Hermelink HK, Roosen K 1997 Inverse correlation of cell proliferation and expression of progesterone receptors in tumor spheroids and monolayer cultures of human meningiomas. Neurosurgery 41: 1152-1159